Statistics
Total Visits
Views | |
---|---|
VEGF-A, VEGFR1 and VEGFR2 single nucleotide polymorphisms and outcomes from the AGITG MAX trial of capecitabine, bevacizumab and mitomycin C in metastatic colorectal cancer | 349 |
Total Visits per Month
November 2023 | December 2023 | January 2024 | February 2024 | March 2024 | April 2024 | May 2024 | |
---|---|---|---|---|---|---|---|
VEGF-A, VEGFR1 and VEGFR2 single nucleotide polymorphisms and outcomes from the AGITG MAX trial of capecitabine, bevacizumab and mitomycin C in metastatic colorectal cancer | 9 | 1 | 7 | 4 | 2 | 9 | 9 |
File Downloads
Views | |
---|---|
hdl_136580.pdf | 173 |
Top Country Views
Views | |
---|---|
Australia | 240 |
United States | 35 |
Poland | 18 |
Vietnam | 9 |
Ireland | 8 |
Belgium | 5 |
China | 5 |
Hong Kong SAR China | 4 |
Singapore | 3 |
Argentina | 2 |
Top City Views
Views | |
---|---|
Gdansk | 18 |
Ashburn | 10 |
Hanoi | 9 |
Dublin | 7 |
Sydney | 7 |
Boardman | 5 |
Brussels | 5 |
Arezzo | 2 |
London | 2 |
Singapore | 2 |